sites on the Pfizer and Moderna #COV19 vaccine trials. Mark Lacy’s Post Mark Lacy 1y Report this post Scott and I are so humbled and grateful Benchmark Research 2,118 followers 1y We're proud to have our CEO and Founder. Sponsors are taking notice and driving a lot of this shift.Īt the outset of COVID, CRIO’s system was leveraged by nearly a quarter of the U.S. Investors built these networks for three unique reasons (that aren’t going away).ġ) Centralized business development places studies at multiple sites with centralized contracting and budgeting.Ģ) Local recruiting x National Marketing makes it easier to fill studies.ģ) Standardized operations and systems mean a single electronic source template for sites with centralized and offshore #EDC entry and other activities. There are 5X as many site networks today as in 2015. Orantes, Co-Chief Diversity Officer of hyperCORE & CEO at Alcanza Clinical Research Nicholas Focil, Chief Quality Management Officer at hyperCORE & CEO FOMAT Medical Research Nathan Morton, Chief Vaccine Officer at hyperCORE & Chief Commercial Officer at Alcanza Clinical Research #researchaccelerated #clinicalresearch #networking #supernetwork ROBERTO Aguirre, Chief Medical Officer at hyperCORE & VP/Global Medical Director at AGA Clinical Trials Carlos E. Samir Arora, Chief Corporate Development Officer of hyperCORE & CGO at Centricity Researchĭr. Jeff Kingsley, COO of hyperCORE & CEO at Centricity Research Jeffrey Smyth, CFO of hyperCORE & Executive Director at TrueBlue Clinical Researchĭr. Mark Lacy, Chairman of hyperCORE & CEO of Benchmark Research Karri Venn, CEO of hyperCORE & COO at Centricity Researchĭr. Say hello to our hyperCORE leadership at World Vaccine Congress: Find out what strategic partnerships within our super network can do to accelerate your #clinicaltrials site capabilities in both quality and #diversity. sites on the Pfizer and Moderna #COV19 vaccine trials.Our leadership team is headed to The World Vaccine Congress 2023 on April 3-6 in Washington, DC, and we look forward to seeing you there! Make sure to schedule a meeting with Michael Casey, Executive Director of hyperCORE, or reach out to our leadership team when you stop by Booth 501. Use the PitchBook Platform to explore the full profile. Samir Arora, Chief Corporate Development Officer of hyperCORE & CGO at Centricity Researchĭr. Information on acquisition, funding, investors, and executives for Benchmark Research. They have also tested the Janssen/Johnson & Johnson and the Novavax vaccines. Say hello to our hyperCORE leadership at World Vaccine Congress: Benchmark Research enrolled 415 people in the Moderna trial and 473 in the Pfizer trial in Austin. Our leadership team is headed to The World Vaccine Congress 2023 on April 3-6 in Washington, DC, and we look forward to seeing you there! Make sure to schedule a meeting with Michael Casey, Executive Director of hyperCORE, or reach out to our leadership team when you stop by Booth 501.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |